Neonatal Intensive Care Unit, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Neonatology. 2014;105(3):218-26. doi: 10.1159/000357207. Epub 2014 Feb 4.
To study whether new pharmacological and nonpharmacological guidelines lowered numbers of painful procedures in neonates and changed the amount and frequency of analgesic therapy as compared to the results of our previous study in 2001.
A prospective observational study.
Level III NICU of the Erasmus MC-Sophia Children's Hospital, Rotterdam.
Neonates admitted at postnatal ages less than 3 days with length of stay at least 72 h.
Number of all potentially painful procedures and analgesic therapy recorded at the bedside during the first 14 days of NICU stay.
A total number of 21,076 procedures were performed in the 175 neonates studied during 1,730 patient-days (mean 12.2). The mean number of painful procedures per neonate per day was 11.4 (SD 5.7), significantly lower than the number of 14.3 (SD 4.0) in 2001 (p < 0.001). The use of analgesics was 36.6% compared to 60.3% in 2001. Sixty-three percent of all peripheral arterial line insertions failed versus 37.5% in 2001 and 9.1% venipunctures failed versus 21% in 2001.
The mean number of painful procedures per NICU patient per day declined. Nonpharmacological pain- or stress-reducing strategies like NIDCAP and sucrose were fully embedded in our pain management. As further reduction of the number of painful procedures is unlikely, we should apply more nonpharmacological interventions and explore newer pharmacological agents.
研究新的药理学和非药理学指南是否降低了新生儿有创操作的数量,并改变了镇痛治疗的剂量和频率,与我们 2001 年的先前研究结果相比。
前瞻性观察研究。
鹿特丹伊拉斯谟医疗中心-索菲亚儿童医院三级新生儿重症监护病房。
生后年龄小于 3 天、入住时间至少 72 小时的新生儿。
新生儿重症监护病房住院期间前 14 天床边记录的所有潜在有创操作和镇痛治疗的数量。
在 175 名研究的新生儿中,共进行了 21076 次操作,共 1730 个患者日(平均 12.2 次)。每名新生儿每天的有创操作数量为 11.4 次(标准差 5.7),明显低于 2001 年的 14.3 次(标准差 4.0)(p<0.001)。与 2001 年的 60.3%相比,镇痛药物使用率为 36.6%。63%的外周动脉置管术失败,而 2001 年为 37.5%,9.1%的静脉穿刺术失败,而 2001 年为 21%。
每名新生儿每天的有创操作数量有所减少。非药物性减轻疼痛或应激的策略,如鸟巢护理和蔗糖,已完全融入我们的疼痛管理中。由于进一步减少有创操作的数量不太可能,我们应该应用更多的非药物干预措施,并探索新的药物。